CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 488.3	$ 645.5
Accounts receivable, net	492.0	472.7
Inventories	968.3	800.1
Assets held for sale	0.0	1.4
Other current assets	215.6	193.5
Total current assets	2,164.2	2,113.2
Property, plant and equipment, net	599.7	487.0
Goodwill	582.6	457.6
Intangible assets, net	330.5	270.9
Operating lease assets	91.7	51.2
Deferred tax assets	297.2	76.8
Other long-term assets	184.0	155.1
Total assets	4,249.9	3,611.8
Current liabilities:
Current portion of long-term debt	121.2	18.7
Accounts payable	202.7	178.4
Deferred revenue and customer advances	400.0	370.2
Other current liabilities	478.2	347.0
Total current Liabilities	1,202.1	914.3
Long-term debt	1,160.3	1,200.5
Long-term deferred revenue and customer advances	91.5	101.6
Deferred tax liabilities	67.7	62.3
Operating lease liabilities	74.8	34.8
Accrued pension	76.6	45.7
Other long-term liabilities	163.6	120.8
Total Liabilities	2,836.6	2,480.0
Commitments and contingencies (Note 18)
Redeemable noncontrolling interests	18.7	6.1
Shareholders' equity:
Preferred stock, $0.01 par value 5,000,000 shares authorized, none issued or outstanding at December 31, 2023 and 2022	0.0	0.0
Common stock, $0.01 par value 260,000,000 shares authorized, 175,943,705 and 175,389,586 shares issued and 145,164,826 and 147,023,144 outstanding at December 31, 2023 and 2022, respectively	1.7	1.7
Treasury stock at cost, 30,778,879 and 28,366,442 shares at December 31, 2023 and 2022, respectively	(1,237.2)	(1,085.0)
Additional paid-in capital	282.9	256.3
Retained earnings	2,323.8	1,926.0
Accumulated other comprehensive income, net of tax	6.0	14.8
Total shareholders' equity attributable to Bruker Corporation	1,377.2	1,113.8
Noncontrolling interests in consolidated subsidiaries	17.4	11.9
Total shareholders' equity	1,394.6	1,125.7
Total liabilities, redeemable noncontrolling interest and shareholders' equity	$ 4,249.9	$ 3,611.8